Get Healthy!

  • Posted October 25, 2024

Popular Diabetes and Weight-loss Drug May Lower Alzheimer’s Risk

A new study finds type 2 diabetes patients taking semaglutide have much lower odds of developing Alzheimer’s disease, regardless of weight, gender or age.

Health News is provided as a service to Crary Drug site users by HealthDay. Crary Drug nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.
Copyright © 2024 HealthDay All Rights Reserved.

Share

Tags